Generic placeholder image

Current Diabetes Reviews


ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

Intravitreal Injections and Diabetic Macular Edema: Actual and New Therapeutic Options

Author(s): Nicola Pescosolido, Federica Pranno and Giuseppe Buomprisco

Volume 9, Issue 6, 2013

Page: [491 - 498] Pages: 8

DOI: 10.2174/15733998113096660083

Price: $65


The management of diabetic macular edema (DME) has been revolutionized in recent years. Focal and focal/ grid laser photocoagulation have been the mainstay of treatment for DME for much time. However, nowadays, there is growing evidence that intravitreal VEGF-inhibitors (combined or not with laser photocoagulation) provide better visual outcome in patients with diabetic retinopathy. Hence, anti-VEGF injections are considered the new gold standard to treat diabetic macular edema and eyes with a reduced visual function. Further studies assessing different treatment regimens are underway to define better clinical care pathways.

Keywords: Anti-VEGF, diabetic macular edema, diabetes, neovascularization, rethinopathy, vision loss prevention.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy